We've found
10,106 Gastrointestinal
clinical trials
We've found
10,106 Gastrointestinal
clinical trials
Crohn's Disease Clinical Trial
Updated: 12/31/1969
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF‑06700841 In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF‑06700841 In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Study To Evaluate The Efficacy And Safety Of Oral PF-06651600 And PF‑06700841 In Subjects With Moderate To Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
Safety and Efficacy of Adalimumab Versus Ustekinumab for One Year
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
Efficacy and Safety of AbGn-168H in Patients With Moderate to Severe Active, Anti-TNF Alpha and/or Anti-integrin Refractory Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/31/1969
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
Hyperbaric Oxygen Therapy for Ulcerative Colitis Flares
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
A Phase I Study Of Etrolizumab Followed By Open-Label Extension And Safety Monitoring In Pediatric Patients With Moderate To Severe Ulcerative Colitis Or Moderate To Severe Crohn's Disease
Status: Enrolling,
Phase
I
Updated: 12/31/1969
Click here to add this to my saved trials

Endocrinology, Gastroenterology Clinical Trial
Updated: 12/31/1969
Early Tracking of Childhood Health Determinants (ETCHED) Study
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
BI 655130 Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis
Status: Enrolling,
Phase
II, III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Pharmacology / Toxicology Clinical Trial
Updated: 12/31/1969
Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Pharmacology / Toxicology Clinical Trial
Updated: 12/31/1969
Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Pharmacology / Toxicology Clinical Trial
Updated: 12/31/1969
Study of ISIS 703802 in Subjects With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Ulcerative Colitis Clinical Trial
Updated: 12/31/1969
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of UTTR1147A Compared With Placebo and With Vedolizumab in Participants With Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn Disease Clinical Trial
Updated: 12/31/1969
An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
Comparison of Phototherapy Using Neolight Skylife Versus Standardized Phototherapy for Hyperbilirubinemia in Newborns
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology Clinical Trial
Updated: 12/31/1969
An Investigational Study of Experimental Medication BMS-986165 in Patients With Moderate to Severe Crohn's Disease
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Gastroenterology, Oncology Clinical Trial
Updated: 12/31/1969
AI-EMERGE: Development and Validation of a Multi-analyte, Blood-based Colorectal Cancer Screening Test
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Colitis, Ulcerative Clinical Trial
Updated: 12/31/1969
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials

Crohn's Disease Clinical Trial
Updated: 12/31/1969
Efficacy and Safety Study of SHP647 as Induction Therapy in Participants With Moderate to Severe Crohn's Disease (CARMEN CD 305)
Status: Enrolling,
Phase
III
Updated: 12/31/1969
Click here to add this to my saved trials
